
Standard Chartered Bank, CCIL IFSC enable real-time US dollar transactions at GIFT City
Under the pact, Standard Chartered Bank IBU will act as the settlement bank for CCIL IFSC Limited's Foreign Exchange Settlement System (FCSS) at GIFT City.
Corporates, business and the financial community will benefit from the US dollar clearing system, as it permits faster settlement of foreign currency transactions within international business units. Subsequently, this will improve the efficiency of fund management for IFSC banking units, investors and other institutions.
'Standard Chartered Bank's appointment as a Settlement Bank at GIFT City is an important milestone in our continued contribution to this critical ecosystem,' said P.D. Singh, CEO, India and South Asia, Standard Chartered Bank.
Having been at the forefront of introducing new products and capabilities at GIFT City, the bank looks forward to utilising its international expertise to make this a world class Banking centre in partnership with CCIL IFSC, Singh added.
The agreement reflects Standard Chartered Bank's commitment to the continued development of GIFT City, in line with the government vision to create a world-class financial centre with a strong reputation in the country.
'CCIL-IFSC's partnership with Standard Chartered Bank is a significant step towards operationalising our Foreign Currency Settlement System that will enable seamless, real-time USD settlements at IFSC, GIFT City,' said Hare Krishna Jena, Managing Director, CCIL and Director, CCIL IFSC Limited.
According to the government, GIFT International Financial Services Centre (IFSC) should be developed as a prominent gateway for global capital flows into India to feed the needs of high-growth sectors over the next two decades.
Finance Minister Nirmala Sitharaman late last month underscored the importance of developing GIFT City into a dynamic smart city, equipped with integrated, modern, and sustainable living infrastructure, and stated that establishing such world-class amenities is essential to attracting top-tier talent from both domestic and international markets.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
5 hours ago
- Time of India
Special economic zone to be set up by Chinese textile group inaugurated in Pakistan capital
Islamabad: Pakistan Prime Minister Shehbaz Sharif on Friday inaugurated a special economic zone (SEZ) in Islamabad to be set up by a Chinese textile group . State-run the Associated Press of Pakistan (APP) reported that the project would generate exports worth USD 400 million for the country. It will be set up by the Chinese textile group Challenge Fashion Private Limited , which is set to invest USD 100 million over five years in the project. PM Sharif welcomed the establishment of an SEZ, saying that the "initiative would facilitate technology transfer, skill development, and sustainable industrial growth". He also met with the company's delegation - led by its chairman Huwang Weiguo , expressing Pakistan's willingness to "take bilateral ties to new heights", APP quoted him as saying. Live Events The prime minister assured the delegation of his government's complete facilitation for setting up the zone as part of the "industrial component of CPEC ," and thanked the delegation for having faith in the Pakistani market, APP reported. The prime minister expressed Pakistan's desire to set up more such units across the country and hoped to benefit from China's textile sector. He also said that "a China-Pakistan Business-to-Business Conference would soon be held in China, providing an opportunity for collaboration between private businesses of both countries," APP reported. Chairman Huwang said he aims to establish a modern textile industry in Pakistan and thanked the prime minister for his support and hospitality. Pakistan and China have strong economic ties and the USD 60 billion China-Pakistan Economic Corridor (CPEC) is a leading exponent of the relationship. Currently, phase II of the programme is being implemented with a focus on industrialisation, development of special economic zones and projects related to clean energy, agriculture and livelihood projects.


Indian Express
5 hours ago
- Indian Express
RVNL targets to launch first Vande Bharat Sleeper train prototype in June 2026; to deliver full 120 train sets by 2032
Vande Bharat Sleeper trains: The Ministry of Railways is working in full swing to ramp up the production of Vande Bharat Sleeper trains. For this, the national transporter awarded the contract to manufacture Vande Bharat Sleeper trains to three companies: BEML, Kinet Railway Solutions (a Joint Venture between Russian rolling stock major TMH and Rail Vikas Nigam Limited – RVNL) and a consortium of Titagarh Rail Systems Limited and Bharat Heavy Engineering Limited (BHEL). Of these, the RVNL-led JV is set to manufacture 120 Vande Bharat Sleeper train sets. The company is expected to unveil the first prototype in June 2026. 'All the roadblocks have been cleared and now it is in advance designing stage and production has started in Latur factory. And we hope to see the first prototype in June '26. And after that, the regular production will start,' MP Singh, Director-Operations, RVNL said, according to an exchange filing. Once the trials are successful and proving trials are held and the prototype is cleared, the regular production will start. 'So, in the next financial year, that is Financial Year '26-27, along with the prototype, we expect to see the regular production of the train sets also,' he said in an earnings conference call on August 12. Speaking during the earnings conference call, Pradeep Gaur, Chairman and Managing Director, RVNL said that the order of 120 train sets will be concluded by 2032. '2032, 5 years total. There is a break up of year wise,' Gaur said, while responding to a question, according to a regulatory filing.


Time of India
6 hours ago
- Time of India
UnitedHealth Group (UNH) stock jumps 12% after Buffett's $1.6B stake — forecast predicts 24% upside, is UNH a must-buy?
UnitedHealth Group (UNH) shares soared 12% on August 15, 2025, after Warren Buffett's Berkshire Hathaway revealed a $1.6 billion stake of over 5 million shares. The surge marks the stock's biggest jump in five years, bringing it back above the key $300 level for the first time since mid-July. Analysts now see potential upside of more than 20%, making UNH a 'must-buy' for investors looking for stability in a turbulent healthcare market. UnitedHealth Group (UNH) stock jumped 12% on August 15, 2025, after Warren Buffett's Berkshire Hathaway revealed a $1.6 billion stake, snapping the insurer out of a recent slump. Shares climbed past the $300 mark, the first time since mid-July, and analysts are now forecasting a potential 24% upside. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Stock Price (Aug 15, 2025): $302.76 Intraday High/Low: $307.90 / $295 After-Hours Gain: 11% Shares Purchased by Berkshire Hathaway: 5 million+ Berkshire Cash Reserve: $344 billion Buffett's Strategic Bet: A Signal of Long-Term Confidence Buffett's broader portfolio strategy Berkshire trimmed Apple (AAPL) and Bank of America (BAC) positions Initiated new stakes in homebuilders like D.R. Horton (DHI) and Lennar Corp Added shares in industrial steelmaker Nucor (NUE) Market Reaction: Berkshire Hathaway's Portfolio Moves Current Price: $302.65 USD $302.65 USD Price Change: +$31.16 (+11.48%) from previous close of $271.49 +$31.16 (+11.48%) from previous close of $271.49 Opening Price: $301.00 USD $301.00 USD Intraday High: $307.90 USD $307.90 USD Intraday Low: $295.00 USD $295.00 USD After-Hours Movement: Shares surged following Buffett's investment announcement Shares surged following Buffett's investment announcement Trading Volume: 30,116,349 shares 30,116,349 shares Key Trigger: Berkshire Hathaway bought over 5 million UnitedHealth shares, valued at ~$1.6 billion Berkshire Hathaway bought over 5 million UnitedHealth shares, valued at ~$1.6 billion Market Sentiment: Strong investor confidence despite regulatory scrutiny over Medicare Advantage billing practices Strong investor confidence despite regulatory scrutiny over Medicare Advantage billing practices Implication: Seen as a vote of confidence in UnitedHealth's long-term growth and stability What this means for UnitedHealth and investors Tired of too many ads? Remove Ads Confidence boost amid regulatory scrutiny: Investors may view Buffett's vote as a backstop to share price volatility. Potential support for growth initiatives: Medicare Advantage expansion and other healthcare services could receive renewed focus. Short-term price resilience: The $300 psychological level may act as a recovered support level, with resistance near $342 and potential upside toward $376.84. Stock forecast and outlook Near-term resistance: $342 $342 Mid-term gap fill: $376.84 $376.84 Long-term former support: $438.50 Expert Takeaway: FAQs: UnitedHealth Group (UNH) stock soared on August 15, 2025, hitting its best day in five years after Warren Buffett's Berkshire Hathaway disclosed a $1.6 billion purchase of over 5 million shares. The move sent the healthcare giant's stock up 12% in after-hours trading, signaling strong investor confidence despite recent regulatory and financial say Buffett's entry comes at a critical time, as UnitedHealth navigates regulatory scrutiny over Medicare Advantage billing practices and has faced a roughly 15% decline in stock value over the past Analysts now see potential upside of more thanfor investors looking for stability in a turbulent healthcare see this as a major endorsement from one of the world's most respected investors, suggesting that UnitedHealth's long-term growth prospects remain robust, particularly in its diversified healthcare services and expanding Medicare Advantage surge also reflects broader market optimism, as institutional and retail investors often follow Buffett's high-profile moves, betting on stability and resilience in a volatile healthcare investment comes as UnitedHealth navigates a challenging landscape. The company has faced federal scrutiny over its Medicare Advantage billing practices and a notable drop in stock value over the past year. Yet, Berkshire Hathaway's purchase is being interpreted by analysts as a robust vote of confidence."Buffett rarely invests on a whim," says financial analyst Linda Chen of Apex Capital. "This signals that UnitedHealth's fundamentals, especially its diversified healthcare services and strong market position, remain highly attractive for long-term investors."This acquisition is part of a strategic reshuffle at Berkshire Hathaway. In Q2 2025:The firm retains a cash reserve of $344 billion, giving Buffett ample room for strategic bets in undervalued or high-potential stock closed at, climbingin after-hours trading on August 15. Intraday, the stock hit a high ofand a low of, with a trading volume exceeding. The sharp uptick reflects investor optimism that Buffett's involvement could stabilize sentiment and boost confidence in UnitedHealth's growth acquisition is part of broader strategic changes in Berkshire Hathaway's portfolio. According to the latest 13F filing, Buffett's firm reduced its stake in Apple by 7%, while initiating new positions in homebuilders likeand, and industrial steel producer. The moves suggest a diversification strategy into sectors with potential long-term gains, even as Berkshire holds a substantial cash reserve ofBuffett's entry could stabilize market sentiment and attract additional institutional interest. For UnitedHealth, the implications include:However, regulatory risks remain. Investigations into Medicare Advantage billing practices could still impact earnings and valuation in the near analysts see UNH trading above its 50-day Simple Moving Average (SMA) for the first time since April, signaling a possible bullish trend. Key targets include:While short-term traders may celebrate the 11% surge, seasoned investors recognize Buffett's hallmark: patient, long-term investing. His move is less about immediate gains and more about UNH's enduring market position and operational short-term traders may celebrate the after-hours surge, seasoned investors recognize Buffett's hallmark: patient, long-term investing. This move underscores his confidence not in immediate gains but in UnitedHealth's enduring market position, operational efficiency, and healthcare sector growth did Warren Buffett invest in UnitedHealth stock today?Buffett bought over $1.6B in UnitedHealth shares, showing confidence in the company's growth and long-term did UnitedHealth shares react after Buffett's purchase?UnitedHealth stock soared 11% after-hours, reaching $302.76, reflecting strong investor optimism.